MEI LYN LAMAR: Open Payments
NPI 1396105185 · ATLANTIC BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,900 in 103 payments from 23 companies in 2025. Trend: 2023 $1,041 · 2024 $3,796 · 2025 $3,900
Food & beverage: $3,800Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $483 |
| Amgen Inc. | 11 | $445 |
| AstraZeneca Pharmaceuticals LP | 7 | $424 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $371 |
| Novo Nordisk Inc | 12 | $331 |
| Phathom Pharmaceuticals, Inc. | 7 | $271 |
| Daiichi Sankyo Inc. | 6 | $239 |
| Boston Scientific Corporation | 2 | $170 |
| PFIZER INC. | 5 | $163 |
| Stryker Corporation | 1 | $140 |
Products named: VOQUEZNA, REPATHA, INJECTAFER, OFEV, FARXIGA, Ozempic, UBRELVY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
